Oncos Therapeutics (Finland)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 4 of 4 papers

  • Open Access
  • Research Article
  • Citations11

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors

  • Mar 01, 2024
  • Journal for ImmunoTherapy of Cancer
  • Sara Feola +14
  • Open Access
  • Research Article
  • Citations54

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.

  • Jul 03, 2014
  • International Journal of Cancer
  • Mikko Siurala +11
  • Open Access
  • PDF
  • Abstract
  • Citations2

Gene expression analysis of tumors demonstrates an induction of Th1 type immune response following intratumoral administration of ONCOS-102 in refractory solid tumor patients

  • Jan 01, 2014
  • Journal for Immunotherapy of Cancer
  • Mamun Majumder +20
  • Research Article

CGTG-102 (Ad5/3-D24-GMCSF), a novel oncolytic adenovirus, in patients with refractory solid tumors: Experience from an advanced therapy access program.

  • May 20, 2012
  • Journal of Clinical Oncology
  • Mikael Von Euler +12
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.